1-Hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborole-5-carboxylic acid, 97%, 1g

3,4-Dibromoanisole, 98.0%, 10g

5-Bromobenzene-1,3-diol, 95.0%, 1g

2-Chloro-6-fluoro-3-methoxyphenol, 95.0%, 5g

2,2-Dimethyl-1-propanol, 99.0%, 1g

4-Methoxy-3-methylbenzyl chloride (stabilised with calcium carbonate), 98.0%, 25g

2-Bromo-5-methoxy-1,3,4-thiadiazole, 95%, 5g

3-Bromo-5-(4-methoxyphenyl)pyridine, 95+%, 1g

GC capillary column ROTI®Cap-1701, 10 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2,5-Difluoro-4-iodopyridine, 97.0%, 1g

Incubator Heratherm Protocol series General Protocol with natural convection, 117 l, IGS100, 1 Piece

4-bromo-1-(chloromethyl)-1H-pyrazole, 1g

(3R,4S)-3-FLUOROOXAN-4-AMINE HCL, 95.0%, 5g